News
Novo Nordisk CEO to step down in the face of rising market challenges
Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma giant cited rising ‘market challenges’ and competition as reasons why it was looking for new leadership.
UnitedHealth stock is rising after declining for eight consecutive sessions, Applied Materials issues a disappointing revenue ...
Health-care companies rose sharply, recouping some losses from earlier in the week. UnitedHealth Group recouped 6% on Friday, but still lost almost one quarter of its value for the week after the ...
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
The U.S. Department of Justice is carrying out a criminal investigation into UnitedHealth Group for possible Medicare fraud, ...
Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...
A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback